Mirae Asset Global Investments Co. Ltd. Has $2.33 Million Stake in Maximus, Inc. (NYSE:MMS)

Mirae Asset Global Investments Co. Ltd. decreased its holdings in Maximus, Inc. (NYSE:MMSFree Report) by 2.1% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 27,730 shares of the health services provider’s stock after selling 594 shares during the quarter. Mirae Asset Global Investments Co. Ltd.’s holdings in Maximus were worth $2,325,000 as of its most recent SEC filing.

Several other institutional investors have also recently bought and sold shares of MMS. FMR LLC raised its position in Maximus by 6.4% in the 3rd quarter. FMR LLC now owns 8,588,189 shares of the health services provider’s stock valued at $641,366,000 after purchasing an additional 514,698 shares during the last quarter. Norges Bank bought a new position in Maximus in the 4th quarter valued at $37,673,000. Stephens Investment Management Group LLC raised its position in Maximus by 68.3% in the 2nd quarter. Stephens Investment Management Group LLC now owns 570,702 shares of the health services provider’s stock valued at $48,230,000 after purchasing an additional 231,666 shares during the last quarter. Van Berkom & Associates Inc. raised its position in Maximus by 22.3% in the 3rd quarter. Van Berkom & Associates Inc. now owns 1,124,238 shares of the health services provider’s stock valued at $83,958,000 after purchasing an additional 204,796 shares during the last quarter. Finally, Assenagon Asset Management S.A. bought a new position in Maximus in the 3rd quarter valued at $13,451,000. Institutional investors own 97.21% of the company’s stock.

Analyst Ratings Changes

Several equities analysts have issued reports on the company. StockNews.com upgraded Maximus from a “hold” rating to a “buy” rating in a research report on Thursday, February 8th. Raymond James cut Maximus from an “outperform” rating to a “market perform” rating in a report on Wednesday, January 3rd.

View Our Latest Report on MMS

Insider Buying and Selling at Maximus

In other Maximus news, CFO David Mutryn sold 8,000 shares of the company’s stock in a transaction on Friday, February 16th. The shares were sold at an average price of $83.95, for a total transaction of $671,600.00. Following the completion of the sale, the chief financial officer now owns 5,124 shares in the company, valued at approximately $430,159.80. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 1.40% of the company’s stock.

Maximus Trading Up 0.3 %

MMS opened at $80.03 on Friday. The firm has a 50 day simple moving average of $82.72 and a 200 day simple moving average of $81.05. Maximus, Inc. has a fifty-two week low of $72.39 and a fifty-two week high of $89.69. The company has a market cap of $4.88 billion, a price-to-earnings ratio of 26.50 and a beta of 0.72. The company has a debt-to-equity ratio of 0.71, a current ratio of 1.69 and a quick ratio of 1.69.

Maximus (NYSE:MMSGet Free Report) last released its earnings results on Wednesday, February 7th. The health services provider reported $1.34 EPS for the quarter, topping analysts’ consensus estimates of $1.28 by $0.06. The firm had revenue of $1.33 billion during the quarter, compared to analyst estimates of $1.29 billion. Maximus had a net margin of 3.73% and a return on equity of 15.68%. The business’s quarterly revenue was up 6.2% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.94 EPS. On average, sell-side analysts anticipate that Maximus, Inc. will post 5.41 earnings per share for the current year.

Maximus Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, May 31st. Shareholders of record on Wednesday, May 15th will be given a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a dividend yield of 1.50%. The ex-dividend date is Tuesday, May 14th. Maximus’s payout ratio is 39.74%.

Maximus Company Profile

(Free Report)

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.

Featured Articles

Institutional Ownership by Quarter for Maximus (NYSE:MMS)

Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.